Health facilities in the Emirate of Abu Dhabi reported that the Abu Dhabi Department of Health identified six requirements for conducting medical research and clinical trials related to the "Covid-19" pandemic, including preventing interference between experiments and submitting periodic reports to the competent authorities, to ensure the safety of the participants in these experiments.
Conditions include preventing interference between clinical trials, emphasizing patient safety, and not permitting registration or involvement of patients in more than one clinical trial at one time, unless there is a clear protocol for compassionate use, and it is explained in the clinical research proposal in advance, and the strict commitment of all researchers The Presidents and the Clinical Trials team at all hospitals participating in the clinical trials document all of what happens during clinical trials in patient files.
The list of requirements included the commitment of all the main researchers to submit periodic reports on the clinical results (recovery, no change, death, and negative events) during the period of conducting the approved clinical trials to the Health Department, in order to strengthen the monitoring of clinical trials at the level of the Abu Dhabi Health Department, and review all Clinical trials involving the use of immune-modifying therapies and drug therapies, and carefully monitored and documented, in addition to keeping and reviewing the death rate, and reviewing the current data for all deaths related to "Covid 19", where the Health Department will conduct further investigations and reviews to determine the leading causes To those deaths.
The department pointed out that the standards for medical research related to humans, and guidelines for clinical trials, work to define the regulatory requirements that health and educational facilities and pharmaceutical companies in the emirate must apply to conduct human research, which includes compliance with patient safety and security standards, which are based on The best international practices adopted in this field, and ensuring that the promotion of human health in the long term is the overarching goal of this research.
The department emphasized that the guiding rules for clinical trials help to provide the organizational guidance and guidance necessary to understand responsibilities, and clarify the requirements for good clinical practice when conducting clinical trials, or the use of investigative therapeutic products in the Emirate of Abu Dhabi, pointing out that medical research conducted in the emirate falls within its responsibilities, And through this, it seeks to ensure the safety and protection of patients in the first place, then to enhance cooperation with leading international institutions, so that health facilities in the emirate are part of the global clinical trials system, which contribute to providing the latest advanced treatment services to achieve the vision of "Abu Dhabi is a healthy society".
The Department of Health in Abu Dhabi had approved, last February, 20 health facilities in the emirate centers for scientific and clinical research, as part of its role in organizing and directing the medical research sector in the emirate, and the efforts devoted to encouraging research that contributes to improving the quality of health care provided, and strengthening The health of the emirate's community.
New methods of treatment and disease prevention
The Department of Health in Abu Dhabi stressed that the field of medical research and clinical research is one of the most important drivers for the quality of the health sector, because of its great role and effective impact in enhancing health services, as the department is keen to benefit from the results of these experiments that open broad horizons to improve the patient experience and support The wheel of knowledge-based economics, by finding new ways to treat and prevent diseases.
20
A health facility in Abu Dhabi accredited as centers of scientific and clinical research.